Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Cell Death & Disease|May 22, 2026
Mitochondria-targeted metformin analogs activate the ER stress-unfolded protein response pathway to drive apoptosis in pancreatic cancerMaria Poimenidou, Jordan M Bobek, Donovan Drouillard, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 12, 2018
A Serum-Induced Transcriptome and Serum Cytokine Signature Obtained at Diagnosis Correlates with the Development of Early Pancreatic Ductal Adenocarcinoma MetastasisSusan Tsai, Laura McOlash, Shuang Jia, et al.
Head & Neck|December 26, 2024
Locked Dimerized CXCL12 Exerts Radiosensitizing Effects in Head and Neck CancerOscar Villarreal Espinosa, Musaddiq Awan, Abdullah A Memon, et al.
Cancer Immunology Research|February 13, 2021
Targeting PIM1-Mediated Metabolism in Myeloid Suppressor Cells to Treat CancerGang Xin, Yao Chen, Paytsar Topchyan, et al.
Cancer Research|September 3, 2015
Pancreatic Cancer Cell Migration and Metastasis Is Regulated by Chemokine-Biased Agonism and Bioenergetic SignalingIshan Roy, Donna M McAllister, Egal Gorse, et al.
Frontiers in Cell and Developmental Biology|July 12, 2021
Inactivation of the Euchromatic Histone-Lysine N-Methyltransferase 2 Pathway in Pancreatic Epithelial Cells Antagonizes Cancer Initiation and Pancreatitis-Associated Promotion by Altering Growth and Immune Gene Expression NetworksGuillermo Urrutia, Thiago Milech de Assuncao, Angela J Mathison, et al.
Cancer Immunology, Immunotherapy : CII|April 15, 2026
Radiation-induced remodeling of the T cell landscape in head and neck cancerAbdullah A Memon, Imaad Said, Ean Norenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2025
Phase I/II Study of Adaptive Manufactured Lentiviral Anti-CD20/Anti-CD19 Chimeric Antigen Receptor T Cells for Relapsed, Refractory Mantle Cell LymphomaNirav N Shah, Alfredo S Colina, Bryon D Johnson, et al.
Cancer Research|August 12, 2021
Oncostatin M Receptor-Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer GrowthAnjali Geethadevi, Ajay Nair, Deepak Parashar, et al.
ACS Pharmacology & Translational Science|January 20, 2023
DPP4-Truncated CXCL12 Alters CXCR4/ACKR3 Signaling, Osteogenic Cell Differentiation, Migration, and SenescenceAhmed M Elmansi, Nada H Eisa, Sudharsan Periyasamy-Thandavan, et al.
Pageof 8